Loading clinical trials...
Loading clinical trials...
Prospective Study of the Natural History, Immunological and Genetic Characteristics of Preclinical Inflammatory Bowel Disease
The purpose of this study is to evaluate disease progression, in terms of development of symptomatic disease and complications associated with IBD (e.g. fistula, abscess, stricture).
This is a prospective, observational, multicenter, collaborative research project that will explore the earlier stages of IBD, before the onset of the first symptoms of the disease. This novel approach constitutes an innovative strategy on the research on the natural history of the disease. The study will be carried out based on colorectal cancer screening colonoscopies, recruiting all patients with a new diagnosis of IBD in this setting. These patients will undergo follow-up visits every 6 months for 10 years and the clinical information will be enriched with longitudinal multi-omic analyses. Two additional control groups will be identified, including patients with new-onset symptomatic IBD in the last 3 months and healthy controls (with normal screening colonoscopy).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Hospital Clínico Universitario de Santiago
Santiago de Compostela, A Coruña, Spain
Hospital General Universitario Dr. Balmis
Alicante, Alicante, Spain
Hospital Universitario Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital de Sant Joan Despí Moisès Broggi
Barcelona, Barcelona, Spain
Althaia, Xarxa Assistencial Universitària de Manresa
Manresa, Barcelona, Spain
Hospital Universitari Mútua de Terrassa
Terrassa, Barcelona, Spain
Hospital Universitario de Basurto
Bilbao, Bilbao, Spain
Hospital Universitario de Burgos
Burgos, Burgos, Spain
Hospital Universitario Reina Sofía
Córdoba, Córdoba, Spain
Hospital Universitario Donostia
Donostia / San Sebastian, Gipuzkoa, Spain
Start Date
June 1, 2024
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2038
Last Updated
February 6, 2026
450
ESTIMATED participants
bioespecimen samples
PROCEDURE
Lead Sponsor
Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06975722